All lobbying filings

B HALL STRATEGIES, LLC

B HALL STRATEGIES, LLC filed a Q3 report for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. on October 20, 2025, reporting $30,000 in lobbying income.

Lobbying for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

All filings by B HALL STRATEGIES, LLC · Everything TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.